Moreover, they found higher enzymatic activity of SIRT2 in postmortem brain tissue from patients with different neurodegenerative diseases (Parkinson’s disease (PD), PD with dementia, dementia with Lewy bodies (DLB), and Alzheimer’s disease (AD)) compared to control samples [50]. This evidence concerns the gene SIRT2 and Alzheimer disease.